Aster implements India’s first IOeRT for cancer care
To set a new standard in oncology, offering highly targeted radiation therapy that improves treatment precision, and accelerates recovery for cancer patients
To set a new standard in oncology, offering highly targeted radiation therapy that improves treatment precision, and accelerates recovery for cancer patients
Teliso-V is an investigational antibody-drug conjugate (ADC) for patients with previously treated nonsquamous non-small cell lung cancer (NSCLC) with c-Met protein overexpression
Mahatma Gandhi Cancer Hospital & Research Institute has emerged as the leading provider of comprehensive cancer care in Viza
Augtyro is the only FDA-approved treatment option for NTRK-positive tumors studied in both TKI-naïve and TKI-pretreated patients across solid tumors
The surgeons were able to remove the entire breast while preserving the nipple through tiny hidden incisions
The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
Marks the World Head & Neck Cancer Day at the OCTF Conference
To bring quality cancer treatment closer to patients, India’s leading MedTech brand is joining forces with the unique technology-led platform
The company is proud to be at the forefront of promoting cancer awareness and hopes to make a positive impact on the lives of its employees
Subscribe To Our Newsletter & Stay Updated